Logo image of WORX

SCWORX CORP (WORX) Stock Fundamental Analysis

NASDAQ:WORX - Nasdaq - US78396V2088 - Common Stock - Currency: USD

1.36  -0.07 (-4.9%)

After market: 1.4 +0.04 (+2.94%)

Fundamental Rating

1

WORX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 39 industry peers in the Health Care Technology industry. WORX has a bad profitability rating. Also its financial health evaluation is rather negative. WORX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WORX had negative earnings in the past year.
WORX had a negative operating cash flow in the past year.
WORX had negative earnings in each of the past 5 years.
WORX had a negative operating cash flow in each of the past 5 years.
WORX Yearly Net Income VS EBIT VS OCF VS FCFWORX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M

1.2 Ratios

With a Return On Assets value of -53.81%, WORX is not doing good in the industry: 70.27% of the companies in the same industry are doing better.
With a Return On Equity value of -78.26%, WORX perfoms like the industry average, outperforming 40.54% of the companies in the same industry.
Industry RankSector Rank
ROA -53.81%
ROE -78.26%
ROIC N/A
ROA(3y)-41.73%
ROA(5y)-61.6%
ROE(3y)-63.35%
ROE(5y)-96.48%
ROIC(3y)N/A
ROIC(5y)N/A
WORX Yearly ROA, ROE, ROICWORX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K -1K

1.3 Margins

WORX has a worse Gross Margin (28.98%) than 78.38% of its industry peers.
In the last couple of years the Gross Margin of WORX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for WORX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.73%
GM growth 5YN/A
WORX Yearly Profit, Operating, Gross MarginsWORX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K

More info and screens

1

2. Health

2.1 Basic Checks

WORX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WORX has been increased compared to 1 year ago.
WORX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for WORX has been reduced compared to a year ago.
WORX Yearly Shares OutstandingWORX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
WORX Yearly Total Debt VS Total AssetsWORX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -6.08, we must say that WORX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.08, WORX is doing worse than 81.08% of the companies in the same industry.
WORX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
WORX's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. WORX outperforms 62.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -6.08
ROIC/WACCN/A
WACC10%
WORX Yearly LT Debt VS Equity VS FCFWORX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

WORX has a Current Ratio of 0.33. This is a bad value and indicates that WORX is not financially healthy enough and could expect problems in meeting its short term obligations.
WORX's Current ratio of 0.33 is on the low side compared to the rest of the industry. WORX is outperformed by 89.19% of its industry peers.
WORX has a Quick Ratio of 0.33. This is a bad value and indicates that WORX is not financially healthy enough and could expect problems in meeting its short term obligations.
WORX has a Quick ratio of 0.33. This is amonst the worse of the industry: WORX underperforms 89.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
WORX Yearly Current Assets VS Current LiabilitesWORX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for WORX have decreased strongly by -65.42% in the last year.
Looking at the last year, WORX shows a very negative growth in Revenue. The Revenue has decreased by -17.96% in the last year.
Measured over the past years, WORX shows a very strong growth in Revenue. The Revenue has been growing by 90.92% on average per year.
EPS 1Y (TTM)-65.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.16%
Revenue 1Y (TTM)-17.96%
Revenue growth 3Y-9.95%
Revenue growth 5Y90.92%
Sales Q2Q%-16.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WORX Yearly Revenue VS EstimatesWORX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
WORX Yearly EPS VS EstimatesWORX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

WORX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WORX Price Earnings VS Forward Price EarningsWORX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WORX Per share dataWORX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WORX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCWORX CORP

NASDAQ:WORX (2/21/2025, 8:00:02 PM)

After market: 1.4 +0.04 (+2.94%)

1.36

-0.07 (-4.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-12 2024-11-12
Earnings (Next)N/A N/A
Inst Owners11.72%
Inst Owner Change2.15%
Ins Owners3.55%
Ins Owner Change0%
Market Cap2.53M
Analysts0
Price TargetN/A
Short Float %2.02%
Short Ratio0.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.78
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS1.73
BVpS2.41
TBVpS-0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -53.81%
ROE -78.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.98%
FCFM N/A
ROA(3y)-41.73%
ROA(5y)-61.6%
ROE(3y)-63.35%
ROE(5y)-96.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.73%
GM growth 5YN/A
F-Score4
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -6.08
F-Score4
WACC10%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.96%
Revenue growth 3Y-9.95%
Revenue growth 5Y90.92%
Sales Q2Q%-16.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.95%
OCF growth 3YN/A
OCF growth 5YN/A